Anastrozole (Arimidex)
-
Post Date:
May 08,2014
-
Expiry Date:
May 08,2015
-
Detailed Description:
Cas No. :120511-73-1
Quantity: 1000Kilograms
Specs:99%
Payment Method: TT
Anastrozole (Arimidex)
CAS: 120511-73-1
Assay: 98.0%--102.0%. USP32
Packing: 1Kg/foil bag.
Delivery: Courier.
MF: C17H19N5
MW: 293.37
Character: White crystalline powder. MP 81-82°C.
Usage: An aromatase inhibitor. Used as an antineoplastic raw materials.
Potent selective triazole aromatase inhibitors, can inhibit the cytochrome P-450 aromatase enzyme which depends blocking the biosynthesis of estrogen, and estrogen to stimulate breast cancer cell growth factors. Treatment of breast cancer, especially for those with hormone relapse after adjuvant therapy after menopause for women with advanced breast cancer.
Antineoplastic Agents
Tamoxifen citrate
Clomifene citrate
Toremifene citrate
Raloxifene HCl
Letrozole (Femara)
Anastrozole (Arimidex)
Exemestane (Aromasin)
Fulvestrant
Capecitabine
Cabazitaxel
Adriamycin HCL
-
CAS Registry Number:
120511-73-1
-
Synonyms:
;Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetionitrile;ICI-D-1033;Arimidex;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha',alpha'-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-;Anastrozol;Anatrozole;ZD-1033, ICI-D-1033, Arimidex;2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile;1,3-benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl- 5-(1h-1,2,4-triazol-1-ylmethyl)-
zd;1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl);2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile);
-
Molecular Formula:
C17H19N5
-
Molecular Weight:
293.37
-
Molecular Structure:
-
Company:
Wuhan Yuancheng Gongchuang Technology Co., Ltd
[ China ]
-
Contact:
Jane Dong
-
Tel:
+86-27-68886737
-
Fax:
+86-27-88048077-995
-
Email:
ycgsales01@yccreate.com
Inquiry